Related Experiment Video
Updated: Jul 26, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Low Dose-Averaged Linear Energy Transfer Contributes to Local Recurrence of Pancreatic Cancer Treated With Carbon Ion
Soichiro Sakamoto1, Takahiro Oike2, Daijiro Kobayashi2
1Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Purpose:
To evaluate the effects of dose-averaged linear energy transfer (LETd) profiles on local control (LC) of pancreatic cancer treated with carbon ion radiation therapy (CIRT).
Methods And Materials:
Data from patients with inoperable pancreatic cancer, treated with CIRT and concurrent chemotherapy between 2013 and 2021, were analyzed retrospectively. The prescribed dose was 55.2 Gy (relative biological effectiveness), administered in 12 fractions. The LETd of CIRT plans were calculated using a previously reported in-house pipeline. The association between tumor LETd profiles and local recurrence (LR) was analyzed.
Results:
The study analyzed 106 patients. The 2-year cumulative LR rate was 20.2% (95% confidence interval [CI], 12.8%-28.9%). Analysis of LETd parameters using a Fine-Gray regression model showed that the minimum LETd (Lmin) for the clinical target volume (CTV) had a significant effect on LR (P = .023). According to the cut-off value of 42.2 keV/µm, determined by time-dependent receiver operating characteristic analysis at 18 months, patients with low CTV Lmin had a significantly greater cumulative LR rate than those with high CTV Lmin (P = .020; 2-year cumulative LR rate, 32.4% [95% CI, 16.6%-49.3%] vs 12.7% [95% CI, 5.8%-22.5%]). Cause-specific proportional hazards models identified CTV Lmin as a significant predictor of LR (hazard ratio, 0.83; [95% CI, 0.71-0.98]; P = .030). CTV Lmin showed a strong, significant negative correlation with CTV (P < .0001, r = -0.52).
Conclusions:
This is the largest study investigating the association between tumor LETd profiles and LC post-CIRT. The results suggest that low LETd within the CTV is associated with poor LC in patients with pancreatic cancer treated with CIRT.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy

